Head-to-head dispatch
AM Rx vs FitRx
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
AM Rx (getamrx.com) is a telehealth platform operated by FitRX, LLC (also operates Zealthy and FitRx).
Marked down on: Active FTC/DOJ lawsuit over deceptive billing and subscription practices
FDAWarning letter issued to FitRX, LLC dba AM RX in June 2026. See the FDA warning-letter database.
Desk Score
FitRx offers brand-name GLP-1s (Ozempic, Wegovy, Zepbound, Mounjaro) with insurance coordination as low as $25/month, plus compounded semaglutide from $151/month without insurance.
Marked down on: Insurance coordination may not work for all plans
FDAWarning letter issued to FitRX, LLC dba FitRx in February 2026. See the FDA warning-letter database.
FitRx takes this head-to-head with the higher Desk Score, 76/100 (C) against 40/100 (C) for AM Rx. AM Rx still holds its ground where its strengths line up with yours.
Desk Score, dimension by dimension
Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.
AM Rx
40/100
C
FitRx
76/100
C
Price transparency
State access
Molecule range
Onboarding speed
Support responsiveness
Licensing & trust
The spec sheet
| Field | AM Rx | FitRx |
|---|---|---|
| Semaglutide | $151/mo (quarterly plan, plus a separate fee, compounded) | $151/mo (quarterly plan, compounded) |
| Tirzepatide | Not disclosed | Not disclosed |
| Coverage | Coverage not published | All 50 states |
| Brand-name | Yes | Yes |
| Oral option | Injectable only | Injectable only |
| Best for | Patients with insurance seeking brand-name GLP-1 access (review regulatory warnings carefully). | Readers who want insured patients seeking brand-name GLP-1 access with compounded fallback. |
| Desk Score | 40/100C | 76/100C |
The verdict
Desk pick — FitRxFitRx takes this head-to-head with the higher Desk Score, 76/100 (C) against 40/100 (C) for AM Rx. AM Rx still holds its ground where its strengths line up with yours.
Choose AM Rx if…
Patients with insurance seeking brand-name GLP-1 access (review regulatory warnings carefully).
$151/mo (quarterly plan, plus a separate fee, compounded) sema · Not disclosed tirz · Coverage not published
FDAWarning letter issued to FitRX, LLC dba AM RX in June 2026. See the FDA warning-letter database.
Choose FitRx if…
Readers who want insured patients seeking brand-name GLP-1 access with compounded fallback.
$151/mo (quarterly plan, compounded) sema · Not disclosed tirz · All 50 states
FDAWarning letter issued to FitRX, LLC dba FitRx in February 2026. See the FDA warning-letter database.
Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we file on a provider reads the same either way. Read full breakdowns: AM Rx · FitRx.
Also here
CoreAge Rx tops every dispatch at 94/100
Whichever of these two you lean toward, the Desk's #1-rated provider outscores them both. The Desk's top dispatch: flat all-in pricing, both molecules, all 50 states — no teaser-rate traps.
More head-to-heads
- AM Rx vs CoreAge Rx
- FitRx vs Vaylen
- AM Rx vs Strut Health
- FitRx vs Ondra Health
- AM Rx vs Invigor Medical
- FitRx vs Vytora Health
Or see the full comparison hub and the complete ranking.
Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.